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Several recent studies indicate that the von Reck- 
linghausen neuroiibromatosis (NFl) gene is located 
near the centromere of chromosome 17 in some fami- 
lies. However, variable expressivity and a very high 
mutation rate suggest that defects at several different 
loci could result in phenotypes categorized as NFl . In 
order to assess this possibility and to map the NFl 
gene more precisely, we have used two polymorphic 
DNA markers from chromosome 17 to screen several 
pedigrees for linkage to NFl. We ascertained a large 
Caucasian pedigree (33 individuals sampled, 17 NFl 
afPect.ed) as well as eight smaller pedigrees and nu- 
clear families (60 individuals sampled, 30 NFL af- 
fected). Here, we report strong evidence of linkage of 
NFl to the centromeric marker D17Zl (maximum lad 
= 4.42) and a weaker suggestion of linkage to the 
ERBAl oncogene (maximum lod = O&7), both at a 
recombination fraction of zero. Since obligate cross- 
overs with NFl were not observed for either marker 
in any of the informative families tested, the possibil- 
ity of NFl locus heterogeneity is not supported. 
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INTRODUCTION 
We have previously excluded linkage of NFl to a 
substantial portion of chromosome 8 in a large Ameri- 
can Caucasian pedigree (Diehl et al., 1987). These 
data contributed to an exclusion map for NFl (Sar- 
farazi et al., 1987). The results of this pooled set of 
mapping data, especially a positive lod score of 1.17 at 
a recombination fraction of 0.1 (Barker et aZ., 1987a) 
for linkage near the centromere of chromosome 17 
(Dl7Zl), suggested this chromosome as one of the 
most likely map locations for the NFl gene. This sug- 
gestion was confirmed by conclusive reports of link- 
age to markers from chromosome 17, including the 
centromeric marker Dl7Zl and pA10-41 (Barker et 
aZ., 1987b) and the nerve growth factor receptor (Sei- 
zinger et al., 1987). However, variable expressivity and 
a very high mutation rate of NFl may be indicative of 
locus heterogeneity for this disease. Among the indi- 
vidual families examined in these previous studies, 
the largest two-point lod score was 1.46, and some 
families exhibited slightly negative lod scores. There- 
fore, we have undertaken additional linkage studies 
using chromosome 17 markers. Our goal is to evaluate 
further the possibility of locus heterogeneity and to 
map precisely the NFl gene for improved diagnostic 
accuracy and to facilitate its cloning and characteriza- 
tion. 
METHODS AND STUDY SUBJECT 
A total of nine American Caucasian NFl pedigrees 
were ascertained and diagnostic examinations were 
performed. Individuals were categorized as affected 
with NFl if two or more of the following criteria were 
satisfied: (1) six cafe-au-h& macules greater than 1.5 
cm in diameter for postpubertal individuals or five 
macules greater than 0.5 cm in diameter before pu- 
berty; (2) one or more neurofibromas (one, if histolog- 
ically confirmed), including plexiform; (3) multiple 
freckles of axilla or groin; (4) two or more Lisch nod- 
ules; (5) one or more optic nerve gliomas; (6) charac- 
teristic bony changes (Holt, 1978); and (7) a first-de- 
gree relative affected with NFl. In no instance did we 
observe nonpenetrant individuals who passed the 
NFl gene to an affected offspring. Blood samples 
were drawn and immortalized cell lines were estab- 
lished using Epstein-Barr virus transformation. DNA 
was extracted using a method described by Bell et al. 
(1981). Restriction endonuclease digestions, Southern 
blotting, and hybridizations were carried out using 
conventional methods (Davis et al., 1986; Feinberg 
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TABLE 1 
Lod Scores for von Recklinghausen 
Neurofibromatosis Chromosome 17 Markers 












0.01 0.05 0.10 0.20 
D17Z1 (EcoRI) 
2.54 2.33 2.05 1.49 
0.08 0.07 005 0.03 
0.82 0.73 0.63 0.41 
0.29 0.26 0.21 0.13 
0.29 0.26 0.21 0.13 
0.29 0.26 0.21 0.13 
4.32 3.90 3.38 2.32 
erbA1 (PuuII and EcoRI) 
0.53 0.49 0.44 0.32 
0.03 0.02 0.02 0.01 












yielded a lod score of 4.42 for all families combined. 
Family UMIl alone (33 individuals scored, 17 NFl 
affected) provided a lod score of 2.60 for linkage be- 
tween D17Zl and NFl, which is close to the accepted 
criterion of 3.0 for demonstration of linkage. The 
ERBAl polymorphisms were much less informative, 
yielding only a combined lod score of 0.57. The degree 
to which these markers were informative corresponds 
to the observed frequencies of their alleles. Based on 
the counting of about 50 independent alleles, the 
three alleles that we observed for D17Zl (2.7 kb only; 
2.7, 2.0, and 1.5 kb; 2.7 and 1.5 kb) exhibited frequen- 
cies of 0.71, 0.27, and 0.02, respectively. In contrast, 
both ERBAl polymorphisms consisted of two alleles 
with frequencies of about 0.96 and 0.04 (respectively, 
EcoRI: 8.5 or 20.0 kb; Puu II: 1.2,0.8, or 2.0 kb). Poly- 
morphisms at the two enzymes utilized for the 
ERBAl probe were not in complete disequilibrium. 
and Vogelstein, 1984). Linkage to NFl was tested for 
the centromeric marker D17Zl using the clone 
p17H8, which is polymorphic when tested with the 
restriction enzyme EcoRI (Willard et al., 1986), and 
the ERBAl oncogene, which is polymorphic for EcoRI 
when tested with the clone pE2A3D (Mathieu- 
Mahul et aZ., 1985) and for PuuII when tested with the 
clone pHE-Al (Rider et aZ., 1987). Linkage analyses to 
other chromosome 17 markers using some of our NFl 
families are reported by Stephens et al. (this volume). 
Our results broaden the conclusion of linkage of 
NFl to the pericentromeric region of chromosome 17. 
The complete absence of obligate crossovers in any of 
the informative families here analyzed reduces the 
likelihood that locus heterogeneity is a common 
source of the observed variable expressivity or high 
mutation rate of NFl. 
A total of 77 individuals (46 NFl affected) were 
codominantly genotyped for D17Z1,80 individuals (46 
NFl affected) for the ERBAl EcoRI polymorphism, 
and 59 individuals (37 NFl affected) for the ERBAl 
PvuII polymorphism. EcoRI and PuuII polymor- 
phisms for ERBAl were combined into haplotypes for 
linkage analysis. We assumed a linear increase of 
penetrance of NFl from 0% at birth to 95% at age 6 
years and thereafter. 
We thank H. Willard for providing the D17Zl DNA clone, S. 
Saule and D. Stehelin for the ERBAl clones, and K. Stephens 
(Collaborative Research Inc.) for establishing cell lines in families 
UMI4-UMIS. Our work was supported by NIH Grant NS23410. 
F.S.C. is an investigator of the Howard Hughes Medical Institute. 
1. 
RESULTS 2. 
The results of our linkage analysis, presented as lod 
scores (Morton, 1955) calculated using the program 
LIPED (Ott, 1974), are presented in Table 1. No obli- 
gate crossovers were observed between either of the 
markers and NFl in any of the families tested. Maxi- 
mum lod scores consequently were estimated at a re- 
combination fraction of zero for both markers. There 
was no obvious difference in the number of informa- 
tive male and female meioses in the data, so the ob- 
served absence of crossovers cannot be attributed to 
sex-specific differences in recombination rates. The 
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